Cargando…

Recurrent Drug-Induced Hypersensitivity Syndrome Following Bortezomib for Multiple Myeloma

Drug-induced hypersensitivity syndrome is a rare, severe, and delayed hypersensitivity reaction that may occur with exposure to a number of medications. Typical implicated medications include aromatic anticonvulsants, sulfonamides, minocycline, dapsone, and allopurinol. Bortezomib is a proteasome in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ambur, Austin B, Nathoo, Rajiv
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2021
Materias:	Dermatology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800392/ https://www.ncbi.nlm.nih.gov/pubmed/35141083 http://dx.doi.org/10.7759/cureus.20830

Ejemplares similares

Recurrent Erythema Multiforme Induced by the Combination of Pembrolizumab and Radiation
por: Ambur, Austin B, et al.
Publicado: (2021)

A Case of Drug-Induced Bullous Pemphigoid With an Isomorphic Response and Updated Review of Koebnerization in Bullous Diseases
por: Ambur, Austin B, et al.
Publicado: (2021)

Multiple Indolent Asymptomatic Yellow-Orange Patches and Plaques
por: Niemann, Andrew A, et al.
Publicado: (2022)

Vitiligo Possibly Triggered by COVID-19 Vaccination
por: Militello, Michelle, et al.
Publicado: (2022)

Collision of Basal Cell Carcinoma and Sebaceous Carcinoma Extirpated With Mohs Micrographic Surgery
por: Ambur, Austin B, et al.
Publicado: (2021)

Cutaneous Multiple Myeloma
por: Miriyala, Leela Krishna Vamsee, et al.
Publicado: (2021)

Early-Onset Drug Hypersensitivity Syndrome in a Man With Pneumonia Due to Pre-sensitization to Olanzapine
por: Sogo, Azusa, et al.
Publicado: (2022)

Isolated Nail Pigmentation Induced by Minocycline: A Case Report
por: Clark, Abigale, et al.
Publicado: (2022)

Scleredema in the Setting of Monoclonal Gammopathy of Unknown Significance With Progression to Multiple Myeloma: A Case Report
por: Nickell, Austin L, et al.
Publicado: (2023)

Increased Risk of Cutaneous Diseases in Multiple Myeloma Patients
por: Buntinx-Krieg, Talayesa, et al.
Publicado: (2020)

A Rare Case of Delayed Hypersensitivity Following COVID-19 Booster Necessitating Treatment With Dupilumab
por: Hanoodi, Maryam, et al.
Publicado: (2023)

Expanding the spectrum of epidermolysis bullosa simplex: Syndromic epidermolysis bullosa simplex with nephropathy and epilepsy secondary to CD151 tetraspanin defect—a case report and review of the literature
por: Dunn, Charles, et al.
Publicado: (2022)

Eosinophilic Fasciitis and Smoldering Multiple Myeloma: An Exceptional Association in Young Adults
por: Jabbouri, Rajaa, et al.
Publicado: (2022)

Cutaneous Lesions of Multiple Myeloma of the Lower Extremity Masquerading as Squamous Cell Carcinoma
por: Clutter, Courtney A, et al.
Publicado: (2020)

Underlying Immune Mechanisms Involved in Cow’s Milk-Induced Hypersensitivity Reactions Manifesting as Atopic Dermatitis
por: Weimer, Derek S, et al.
Publicado: (2022)

Recurrent Leflunomide-Induced Drug Reaction With Eosinophilia and Systemic Symptom (DRESS) Syndrome Despite Prolonged Steroid Taper: A Case Report
por: Gayfield, Scott, et al.
Publicado: (2022)

A Case of Drug-Induced Hepatitis due to Bortezomib in Multiple Myeloma
por: Kim, Youngwoon, et al.
Publicado: (2012)

Bortezomib in the management of multiple myeloma
por: Laubach, Jacob P, et al.
Publicado: (2009)

Tumor lysis syndrome in multiple myeloma treated with bortezomib
por: Dhanraj, K. M., et al.
Publicado: (2014)

Bortezomib-induced painful neuropathy in patients with multiple myeloma
por: Bilińska, Małgorzata, et al.
Publicado: (2013)

Bortezomib-Induced Reticular Eruption in Patient with Multiple Myeloma
por: Han, Joseph, et al.
Publicado: (2023)

A Case of Recurrent Fixed Drug Eruption Secondary to Desloratadine
por: Almukhadeb, Eman
Publicado: (2021)

Bortezomib (Velcade™) in the Treatment of Multiple Myeloma
por: Field-Smith, Antonia, et al.
Publicado: (2006)

Recurrent Erythema Multiforme Major Following COVID-19 Infection
por: Rykiel, Kayla, et al.
Publicado: (2023)

Recurrent Steven-Johnson/Toxic Epidermal Necrolysis Overlap Syndrome
por: Toledo-Martinez, Juan F, et al.
Publicado: (2022)

Recurrent Cutaneous Pyogenic Granuloma of the Nose Following Rhinoplasty: A Case Report
por: Alghamdi Jr., Fareeda S, et al.
Publicado: (2022)

Multiple Trichoepithelioma Syndrome: A Case Report
por: Guerreiro, Frederico P, et al.
Publicado: (2023)

Delayed Recurrent Erythema Nodosum Following COVID-19 Vaccine: A Case Report
por: Alghamdi, Nada, et al.
Publicado: (2023)

Non-aromatic Anticonvulsant (Divalproex Sodium)-Induced Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome
por: Dutta, Priyata, et al.
Publicado: (2021)

Drug-Induced Stevens-Johnson Syndrome Without Skin Manifestations: A Case Report and Review of Literature
por: Alsulami, Seham, et al.
Publicado: (2023)

Recurrent Significant Bleeding From Abdominal Wall Giant Pyogenic Granuloma Requiring Multiple Blood Transfusions
por: Ahmed, Mohamed, et al.
Publicado: (2022)

Bortezomib Treatment Modulates Autophagy in Multiple Myeloma
por: Di Lernia, Giuseppe, et al.
Publicado: (2020)

Entinostat-Bortezomib Hybrids against Multiple Myeloma
por: Ferro, Angelica, et al.
Publicado: (2023)

Circulating Exosomal CircMYC Is Associated with Recurrence and Bortezomib Resistance in Patients with Multiple Myeloma
por: Luo, Yanwei, et al.
Publicado: (2020)

Gambogenic acid synergistically potentiates bortezomib-induced apoptosis in multiple myeloma
por: Chen, Runzhe, et al.
Publicado: (2017)

Drug-Induced IgA Vasculitis in an Adult
por: Yousif, Miranda, et al.
Publicado: (2023)

Bortezomib: the evidence of its clinical impact in multiple myeloma
por: Lancaster, Simon
Publicado: (2006)

Subcutaneous bortezomib for multiple myeloma treatment: patients’ benefits
por: Petrucci, Maria Teresa, et al.
Publicado: (2014)

Update on the optimal use of bortezomib in the treatment of multiple myeloma
por: Mohan, Meera, et al.
Publicado: (2017)

A feline case of multiple myeloma treated with bortezomib
por: Tani, Hiroyuki, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_amm4etd734fu8csvkbpkin81i3